Accurate molecular classification of human cancers based on gene expression using a simple classifier with a pathological tree-based framework.

[1]  E. Lander,et al.  A molecular signature of metastasis in primary solid tumors , 2003, Nature Genetics.

[2]  David E. Misek,et al.  Gene-expression profiles predict survival of patients with lung adenocarcinoma , 2002, Nature Medicine.

[3]  Kathleen R. Cho,et al.  Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas. , 2002, Cancer research.

[4]  R. Tibshirani,et al.  Diagnosis of multiple cancer types by shrunken centroids of gene expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[5]  S. Dudoit,et al.  Comparison of Discrimination Methods for the Classification of Tumors Using Gene Expression Data , 2002 .

[6]  T. Poggio,et al.  Multiclass cancer diagnosis using tumor gene expression signatures , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[7]  J. Welsh,et al.  Molecular classification of human carcinomas by use of gene expression signatures. , 2001, Cancer research.

[8]  G Rennert,et al.  Organ-specific molecular classification of primary lung, colon, and ovarian adenocarcinomas using gene expression profiles. , 2001, The American journal of pathology.

[9]  David E. Misek,et al.  Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis. , 2001, Cancer research.

[10]  Sayan Mukherjee,et al.  Molecular classification of multiple tumor types , 2001, ISMB.

[11]  H. Gharib,et al.  Anaplastic thyroid carcinoma: current diagnosis and treatment. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

[12]  K. Busam,et al.  Melan-A, a new melanocytic differentiation marker. , 1999, Advances in anatomic pathology.

[13]  R. Cartun,et al.  Utilization of monoclonal antibody L26 in the identification and confirmation of B-cell lymphomas. A sensitive and specific marker applicable to formalin-and B5-fixed, paraffin-embedded tissues. , 1987, The American journal of pathology.

[14]  R. McLendon,et al.  The Immunohistochemical Application of Three Anti‐GFAP Monoclonal Antibodies to Formalin‐fixed, Paraffin‐embedded, Normal and Neoplastic Brain Tissues , 1986, Journal of neuropathology and experimental neurology.